Huiwen Hao and Yansen Zhen have contributed equally to this hypothesis.
A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA
Version of Record online: 30 APR 2013
© 2013 International Federation for Cell Biology
Cell Biology International
Volume 37, Issue 8, pages 860–864, August 2013
How to Cite
Hao, H., Zhen, Y., Wang, Z., Chen, F. and Xie, X. (2013), A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA. Cell Biology International, 37: 860–864. doi: 10.1002/cbin.10112
- Issue online: 10 JUL 2013
- Version of Record online: 30 APR 2013
- Accepted manuscript online: 10 APR 2013 10:36PM EST
- Manuscript Received: 23 OCT 2012
- Manuscript Accepted: 29 MAR 2012
- The National Innovation Experiment Program for University Students. Grant Number: 10697201013
- Natural Science Foundation of China. Grant Number: J1210063
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!